{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:01:22Z","timestamp":1791860482944,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":2202,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"crossref","award":["2009-342"],"award-info":[{"award-number":["2009-342"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"crossref","award":["INCa-DGOS-Inserm 6046"],"award-info":[{"award-number":["INCa-DGOS-Inserm 6046"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1093\/annonc\/mdt391","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T13:40:58Z","timestamp":1383054058000},"page":"2922-2926","source":"Crossref","is-referenced-by-count":97,"title":["GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group\/US and French National Cancer Institute Single-Arm Phase II Collaborative Study"],"prefix":"10.1016","volume":"24","author":[{"given":"A.","family":"Italiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Le Cesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bellera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Piperno-Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Duffaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Takebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Coindre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt391_bb0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2007-0237","article-title":"The clinical approach towards chondrosarcoma","volume":"13","author":"Gelderblom","year":"2008","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdt391_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrc3079","article-title":"The Hedgehog's tale: developing strategies for targeting cancer","volume":"11","author":"Ng","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/annonc\/mdt391_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2353\/ajpath.2006.050001","article-title":"Constitutive Hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation","volume":"168","author":"Tiet","year":"2006","journal-title":"Am J Pathol"},{"issue":"Suppl. 1","key":"10.1093\/annonc\/mdt391_bb0025","article-title":"Direct targeting of the Hedgehog pathway in primary chondrosarcoma xenografts with the Smoothened inhibitor IPI-926","volume":"71","author":"Campbell","year":"2011","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt391_bb0030","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1158\/1078-0432.CCR-12-0568","article-title":"Vismedogib","volume":"18","author":"Rudin","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt391_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdt391_bb0040","series-title":"SEER Cancer Statistics Review, 1975\u20132004","author":"Ries","year":"2007"},{"key":"10.1093\/annonc\/mdt391_bb0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2106\/JBJS.H.00416","article-title":"Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database","volume":"91","author":"Giuffrida","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1093\/annonc\/mdt391_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"issue":"Suppl. 2","key":"10.1093\/annonc\/mdt391_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1634\/theoncologist.13-S2-27","article-title":"Other endpoints in screening studies for soft tissue sarcomas","volume":"13","author":"Verweij","year":"2008","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdt391_bb0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/annonc\/mds470","article-title":"Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy","volume":"24","author":"Penel","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt391_bb0065","first-page":"1079","article-title":"There are no bad anticancer agents, only bad clinical trial designs\u2014Twenty-First Richard and Hinda Rosenthal Foundation Award Lecture","volume":"4","author":"Von Hoff","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt391_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0197-2456(00)00058-1","article-title":"Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint","volume":"21","author":"Mick","year":"2000","journal-title":"Control Clin Trials"},{"key":"10.1093\/annonc\/mdt391_bb0075","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/annonc\/mdr512","article-title":"Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance","volume":"23","author":"van Oosterwijk","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt391_bb0080","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/annonc\/mdt374","article-title":"Advanced chondrosarcomas: role of chemotherapy and survival","volume":"24","author":"Italiano","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdt391_bb0085","article-title":"Outcome of advanced inoperable central chondrosarcoma","author":"Picci","year":"2012","journal-title":"CTOS Annual Meeting"},{"key":"10.1093\/annonc\/mdt391_bb0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/34201","article-title":"Activating Smoothened mutations in sporadic basal-cell carcinoma","volume":"391","author":"Xie","year":"1998","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdt391_bb0095","first-page":"2581","article-title":"Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system","volume":"57","author":"Wolter","year":"1997","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt391_bb0100","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-10-2745","article-title":"Phase I trial of Hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors","volume":"17","author":"LoRusso","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt391_bb0105","doi-asserted-by":"crossref","first-page":"e37006","DOI":"10.1371\/journal.pone.0037006","article-title":"Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic Hedgehog signaling in human breast cancer cells","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1093\/annonc\/mdt391_bb0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-4598-8-28","article-title":"siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells","volume":"8","author":"Kim","year":"2009","journal-title":"Mol Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419373752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419373752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/11\/2922\/16701913\/mdt391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T05:08:15Z","timestamp":1624684095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419373752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0923753419373752"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt391","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}